Reliability and validity of the GMFM-66 in 0- to 3-year-old children with cerebral palsy

Shi Wei1, Wang Su-Juan, Liao Yuan-Gui

  • 1Rehabilitation Center, Children's Hospital, Fudan University, 183 FengLin Road, Shanghai 200-032, China.

Insights

The Gross Motor Function Measure-66 (GMFM-66) reliably and validly assesses gross motor function in young children with cerebral palsy. A newer GMFM-73 version showed no significant advantage for this age group.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Biostatistics

Background:

  • Cerebral palsy (CP) significantly impacts gross motor function in children.
  • Accurate assessment tools are crucial for monitoring development and intervention effectiveness.
  • The Gross Motor Function Measure (GMFM) is widely used, but its suitability for very young children (<3 years) requires examination.

Purpose of the Study:

  • To evaluate the reliability and validity of the 66-item Gross Motor Function Measure (GMFM-66) for assessing gross motor function in children under three years old with cerebral palsy.
  • To compare the performance of the GMFM-66 with a newly developed 73-item version (GMFM-73) in this population.

Main Methods:

  • Utilized data from 171 children with cerebral palsy (age range 3-36 months).
  • Administered both the GMFM-88 and subsequently derived GMFM-66 and GMFM-73 versions.
  • Assessed test-retest and interscorer reliability, and correlated scores and change scores between GMFM-66 and GMFM-73.

Main Results:

  • The GMFM-66 demonstrated high test-retest (ICC=0.9666) and interscorer (ICC=0.9782) reliability.
  • Strong correlations were observed between GMFM-66 and GMFM-73 scores (r=0.9848) and change scores (r=0.8700).
  • The GMFM-73 offered only a marginal 14% gain in relative precision compared to the GMFM-66.

Conclusions:

  • The GMFM-66 is a reliable and valid tool for assessing gross motor function in young children (<3 years) with cerebral palsy.
  • The GMFM-73 did not provide significantly superior performance for this specific pediatric population compared to the GMFM-66.
Abstract

Related Concept Videos